Related Experiment Videos

Local anesthetic blockade of Ca2+ -mediated action potentials in cardiac muscle

Insights

Local anesthetics and diphenylhydantoin block cardiac slow electrical responses by affecting calcium and sodium channels. These drugs also impact normal action potentials, suggesting membrane interactions are key.

Area of Science:

  • Cardiovascular Pharmacology
  • Electrophysiology
  • Cell Membrane Biology

Background:

  • Cardiac muscle cells exhibit slow electrical responses dependent on Ca2+--Na+ channels.
  • Positive inotropic agents increase available slow channels, enabling these responses.
  • Previous work established that certain agents modulate these slow responses.

Purpose of the Study:

  • To investigate the effects of local anesthetics (lidocaine, procaine, cocaine) and diphenylhydantoin (DPH) on cardiac slow electrical responses.
  • To compare these effects with the drugs' actions on normal cardiac action potentials.
  • To elucidate the mechanism of action, particularly channel interactions.

Main Methods:

  • Studied embryonic chick ventricular myocardial cells (intact hearts and cell cultures).
  • Induced slow responses using isoproterenol or caffeine in cells rendered inexcitable (TTX or high K+).
  • Administered local anesthetics and DPH at various concentrations (10^-5 M to 10^-3 M) and assessed electrical responses and contractions.

Main Results:

  • High concentrations (10^-3 M) of all tested drugs blocked induced slow responses and contractions.
  • Low concentrations (10^-5 M) reduced the maximal rate of rise (+Vmax) of slow responses and depressed contractions.
  • All drugs depressed the normal action potential's rate of rise, with higher concentrations causing blockade; low concentrations of lidocaine and DPH increased +Vmax.

Conclusions:

  • Local anesthetics and DPH interfere with cardiac slow Ca2+--Na+ channels.
  • These drugs also affect fast Na+ channels involved in normal action potentials.
  • Findings suggest local anesthetics interact with the myocardial sarcolemma's lipid phase, leading to channel blockade.

Related Concept Videos